Video

Drug delivery vs drops: Controlling postop pain, inflammation in cataract surgery patients

Author(s):

David Hutton,Alex Delaney-Gesing
Conferences|AAO

John A. Hovanesian, MD, discusses the highlights of his presentation on a clinical study evaluating dexamethasone vs prednisolone acetate 1% in controlling postop pain/inflammation in sequential cataract surgery patients.


John A. Hovanesian, MD, clinical instructor, UCLA Jules Stein Eye Institute, Laguna Hills, CA, discusses the highlights of his presentation titled "The D3 Study: Drug Delivery vs Drops — A Prospective Clinical Study Evaluating Dexycu vs Prednisolone Acetate 1% in Controlling Post-operative Pain and Inflammation in Patients Undergoing Sequential Cataract Surgery," during the virtual 2020 American Academy of Ophthalmology (AAO) meeting.

See more AAO coverage here

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
Related Content
Apellis announces 5 abstracts to be orally presented at the American Society of Retina Specialists (ASRS) annual meeting
July 15th 2025

Apellis announces 5 abstracts to be orally presented at the American Society of Retina Specialists (ASRS) annual meeting

3 Things You Should Know About the GA Pipeline
June 4th 2025

3 Things You Should Know About Interventional Glaucoma Comanagement

Alcon’s Clareon PanOptix Pro IOL approved in Canada for cataract patients
July 10th 2025

Alcon’s Clareon PanOptix Pro IOL approved in Canada for cataract patients

Patient-Centered Treatment Strategies in the Management of nAMD and DME
May 30th 2025

Patient-Centered Treatment Strategies in the Management of nAMD and DME

(Image credit: AdobeStock/sakurra) Balwantray C. Chauhan, PhD: In vivo functional imaging of single retinal ganglion cells with two-photon imaging
July 7th 2025

Balwantray C. Chauhan, PhD, explores in vivo functional imaging of single retinal ganglion cells with two-photon imaging

Lupin receives FDA approval for Loteprednol Etabonate Ophthalmic Gel, 0.38%
July 3rd 2025

Lupin receives FDA approval for Loteprednol Etabonate Ophthalmic Gel, 0.38%

© 2025 MJH Life Sciences

All rights reserved.